Literature DB >> 2443719

S4-alpha mRNA translation repression complex. I. Thermodynamics of formation.

I C Deckman1, D E Draper, M S Thomas.   

Abstract

Expression of the four ribosomal proteins from the Escherichia coli alpha operon (S4, S11, S13, and L17) is regulated at the level of translation by the binding of S4 to the alpha mRNA. Using a filter binding assay and alpha mRNA sequences prepared by in-vitro transcription, previous work located the S4 target site within the approximately 100-base leader sequence. We have extended this work to include fragments of the alpha leader with six different 5' end points and four different 3' end points. A core region between bases 23 and 69 (numbering from the first nucleotide of the E. coli transcript) binds S4 with an affinity of approximately 2 microM-1. Regions of weak interactions are located in the 22 nucleotides 5' and the 70 nucleotides 3' to this core; they increase the S4 affinity to approximately 13 microM-1. Studies of S4-alpha mRNA binding under different conditions have revealed the following. (1) Specific and non-specific binding show the same dependence on K+ concentration, with delta log+ K/delta log [K+] approximately 4 in most potassium salts. With KCl and KBr, much weaker salt dependence of specific complex formation is observed suggesting that the protein responds to the correct RNA substrate by binding halide anions. (2) Increasing the MgCl2 concentration between 1 and 4 mM enhances binding by a factor of 4, with no further effects up to 20 mM. About five Mg2+ are taken up by the complex with an average binding constant of approximately 600 M-1 each. Renaturation of the RNA in the presence of MgCl2 is also required to obtain full binding. These effects are seen only with alpha mRNA extending beyond the initiation codon; S4 binding to the alpha leader sequence itself is insensitive to Mg2+. (3) The association kinetics are fast and probably diffusion controlled. (4) Formation of the complex is entirely entropy driven.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443719     DOI: 10.1016/0022-2836(87)90692-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Preferential binding of yeast tRNA ligase to pre-tRNA substrates.

Authors:  B L Apostol; C L Greer
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  Allosteric mechanism for translational repression in the Escherichia coli alpha operon.

Authors:  G Spedding; D E Draper
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

3.  The crystal structure of ribosomal protein S4 reveals a two-domain molecule with an extensive RNA-binding surface: one domain shows structural homology to the ETS DNA-binding motif.

Authors:  C Davies; R B Gerstner; D E Draper; V Ramakrishnan; S W White
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

4.  The solution structure of ribosomal protein S4 delta41 reveals two subdomains and a positively charged surface that may interact with RNA.

Authors:  M A Markus; R B Gerstner; D E Draper; D A Torchia
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

5.  Cloning and analysis of the Bacillus subtilis rpsD gene, encoding ribosomal protein S4.

Authors:  F J Grundy; T M Henkin
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

6.  FljA-mediated posttranscriptional control of phase 1 flagellin expression in flagellar phase variation of Salmonella enterica serovar Typhimurium.

Authors:  Shouji Yamamoto; Kazuhiro Kutsukake
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

7.  Mutational analysis of the RNA pseudoknot component of a coronavirus ribosomal frameshifting signal.

Authors:  I Brierley; N J Rolley; A J Jenner; S C Inglis
Journal:  J Mol Biol       Date:  1991-08-20       Impact factor: 5.469

Review 8.  Frameshifting RNA pseudoknots: structure and mechanism.

Authors:  David P Giedroc; Peter V Cornish
Journal:  Virus Res       Date:  2008-07-25       Impact factor: 3.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.